Literature DB >> 2050915

Identification of false positive exercise tests with use of electrocardiographic criteria: a possible role for atrial repolarization waves.

P M Sapin1, G Koch, M B Blauwet, J J McCarthy, S W Hinds, L S Gettes.   

Abstract

Atrial repolarization waves are opposite in direction to P waves, may have a magnitude of 100 to 200 mu V and may extend into the ST segment and T wave. It was postulated that exaggerated atrial repolarization waves during exercise could produce ST segment depression mimicking myocardial ischemia. The P waves, PR segments and ST segments were studied in leads II, III, aVF and V4 to V6 in 69 patients whose exercise electrocardiogram (ECG) suggested ischemia (100 mu V horizontal or 150 mu V upsloping ST depression 80 ms after the J point). All had a normal ECG at rest. The exercise test in 25 patients (52% male, mean age 53 years) was deemed false positive because of normal coronary arteriograms and left ventricular function (5 patients) or normal stress single photon emission computed tomographic thallium or gated blood pool scans (16 patients), or both (4 patients). Forty-four patients with a similar age and gender distribution, anginal chest pain and at least one coronary stenosis greater than or equal to 80% served as a true positive control group. The false positive group was characterized by 1) markedly downsloping PR segments at peak exercise, 2) longer exercise time and more rapid peak exercise heart rate than those of the true positive group, and 3) absence of exercise-induced chest pain. The false positive group also displayed significantly greater absolute P wave amplitudes at peak exercise and greater augmentation of P wave amplitude by exercise in all six ECG leads than were observed in the true positive group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050915     DOI: 10.1016/s0735-1097(10)80228-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Concerning falsely negative and falsely positive electrocardiographic responses to exercise.

Authors:  L S Gettes; P Sapin
Journal:  Br Heart J       Date:  1993-09

Review 2.  ST segment analysis by Holter Monitoring: methodological considerations.

Authors:  Preben Bjerregaard; Amr El-Shafei; Susan L Kotar; Arthur J Labovitz
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

3.  Detailed ECG analysis of atrial repolarization in humans.

Authors:  Fredrik Holmqvist; Jonas Carlson; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

4.  Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.

Authors:  Domenico Rendina; Renato Ippolito; Gianpaolo De Filippo; Riccardo Muscariello; Daniela De Palma; Silvana De Bonis; Michele Schiano di Cola; Domenico Benvenuto; Maurizio Galderisi; Pasquale Strazzullo; Ferruccio Galletti
Journal:  Intern Emerg Med       Date:  2016-08-26       Impact factor: 3.397

5.  ST segment "hump" during exercise testing and the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  Andreas P Michaelides; Ilias Stamatopoulos; Charalambos Antoniades; Aris Anastasakis; Christina Kotsiopoulou; Artemisia Theopistou; Maria Misailidou; Christos Fourlas; Perry M Elliott; Christodoulos Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

6.  Dynamic detection and reversal of myocardial ischemia using an artificially intelligent bioelectronic medicine.

Authors:  Patrick D Ganzer; Masoud S Loeian; Steve R Roof; Bunyen Teng; Luan Lin; David A Friedenberg; Ian W Baumgart; Eric C Meyers; Keum S Chun; Adam Rich; Allison L Tsao; William W Muir; Doug J Weber; Robert L Hamlin
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

Review 7.  Overview of exercise stress testing.

Authors:  Suleiman M Kharabsheh; Abdulaziz Al-Sugair; Jehad Al-Buraiki; Juman Al-Farhan
Journal:  Ann Saudi Med       Date:  2006 Jan-Feb       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.